Scholars Central

Mini reviewPublished 31 May 2021

Naturido Could Modulate Glia-Neuron Interactions

Authors: Koichi Suzuki, Tetsuro Shinada, Zhou Wu

1Biococoon Laboratories, Inc., Ueda, Morioka, Japan; 2Graduate School of Science, Osaka City University, Osaka, Japan; 3Department of Aging Science and Pharmacology, Kyushu University, Fukuoka, Japan; 4DBT Research Center, Kyushu University, Fukuoka, Japan

Journal of Alzheimers Disease & Parkinsonism

Volume 11 · Issue 5 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Our groups recently published that a novel cyclic peptide (Naturido) modulates glia-neuron interactions in vitro and reverses aging-related deficits in senescence-accelerated mice. This article suggests that Naturido is a promising glia-neuron modulator for the treatment of not only senescence, but also Alzheimer’s disease (AD) and other neurodegenerative disorders. We briefly review the main points of this article.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Koichi Suzuki”
  • BylineArticles whose byline prints “Tetsuro Shinada”
  • BylineArticles whose byline prints “Zhou Wu”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels